mesalamine has been researched along with Orphan Diseases in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Orphan Diseases: Rare diseases that have not been well studied.
Excerpt | Relevance | Reference |
---|---|---|
"At least 1% of patients with Crohn's disease develop amyloidosis." | 2.45 | Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature. ( Basturk, T; Kusaslan, R; Ozagari, A; Ozturk, T; Unsal, A, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basturk, T | 1 |
Ozagari, A | 1 |
Ozturk, T | 1 |
Kusaslan, R | 1 |
Unsal, A | 1 |
1 review available for mesalamine and Orphan Diseases
Article | Year |
---|---|
Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
Topics: Adult; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colchicine; Crohn Disease; Dise | 2009 |